Ablation of the tumor suppressor phosophatase and tensin homlog (PTEN) unexpectedly suppresses the development of pre-B acute lymphoblastic leukemia (ALL).
This is a preview of subscription content, access via your institution
Access options
References
Sulis, M.L. & Parsons, R. Trends Cell Biol. 13, 478–483 (2003).
Hollander, M.C., Blumenthal, G.M. & Dennis, P.A. Nat. Rev. Cancer 11, 289–301 (2011).
Chen, Z. et al. J. Immunol. 195, 5461–5471 (2015).
Suzuki, A. et al. J. Exp. Med. 197, 657–667 (2003).
Ramadani, F. et al. Sci. Signal. 3, ra60 (2010).
Srinivasan, L. et al. Cell 139, 573–586 (2009).
Keenan, R.A. et al. Science 321, 696–699 (2008).
Deau, M.C. et al. J. Clin. Invest. 124, 3923–3928 (2014).
Eswaran, J. et al. Leukemia 29, 1623–1631 (2015).
Shojaee, S. et al. Nat. Med. 22, 379–387 (2016).
Bassi, C. et al. Science 341, 395–399 (2013).
Nogueira, V. et al. Cancer Cell 14, 458–470 (2008).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Fortin, J., Bassi, C. & Mak, T. PTEN enables the development of pre-B acute lymphoblastic leukemia. Nat Med 22, 339–340 (2016). https://doi.org/10.1038/nm.4083
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.4083